Well, negotiations are under way with Merck and other companies to work more closely together hopefully. We've already achieved significant price reductions for two of the recent therapies. But in the future, we frankly want more flexibility when it comes to licenses and other legal issues. Are we going to talk about this in terms of breaking a patent or saving lives?